Rivastigmine Tartrate Capsule
Product Images NDC 55111-355

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Rivastigmine Tartrate (NDC 55111-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

FDA Label Image

Container4 (Container4)

FDA Label Image

Container1 (Contianer1)

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

The text seems to be a part of a chart or graph with some numerical and graphical data. Therefore, it doesn't provide a complete description of any entity, product, or service, and is not useful as is. It might be necessary to obtain additional information or context to generate a meaningful description.*

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

This appears to be a chart displaying the ADAS-cog rating for clinical improvement and decline, with the mean change from baseline displayed for weeks 0, 12, 18 and 2%.*

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Fig6 (Fig6)

FDA Label Image

Fig7 (Fig7)

FDA Label Image

Fig8 (Fig8)

Not-Available*

FDA Label Image

Structure (Structure)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.